# Jennifer Jin

> Jennifer Jin is a Series B investor at Advantech Capital backing Medical. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Advantech Capital](https://shizune.co/investors/profile/advantech-capital)
- Location: Central, Hong Kong
- Total investments: 1
- Last investment: Jan 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jinjennifer/

Jennifer Jin is a Series B investor at Advantech Capital in Central focused on Medical and Health Care. Jennifer Jin is the Partner of Advantech Capital.

## Contacts

5 contacts available for Jennifer Jin: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/jennifer-jin?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Clinical Trials | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Connect Biopharmaceuticals | Connect Biopharmaceuticals is a clinical-stage company that discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation. They identify and advance our drug candidates through in-house discovery and in-licensing while leveraging qualified CROs for further development. The company successfully completed a phase Iclinical trial study on our leading program CBP-307, a novel and selective second-generation S1P1 (a G-protein coupled receptor -GPCR) modulator for the treatment of a range of autoimmune disorders, including multiple sclerosis, inflammatory bowel disease, and psoriasis.Connect Biopharmaceuticals currently conducting two phases 2 clinical studies in patients with ulcerative colitis and Crohn's disease with their lead drug candidate CBP-307. It also concluding a phase 1 study of our second drug candidate CBP-201 in healthy subjects, with a phase 1b study in atopic dermatitis patients expected to commence in Q1, 2019. Connect Biopharmaceuticals was founded in 2012 and is headquartered in Taichang, China. | $55M | Series B | Jan 03, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [Cowin Capital](https://shizune.co/investors/profile/cowin-capital) — VC Fund, 1 deal together
- [Northern Light Venture Capital](https://shizune.co/investors/profile/northern-light-venture-capital) — VC Fund, 1 deal together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 1 deal together

## About Advantech Capital

VC Fund · Central, Hong Kong

Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.

5 contacts available at Advantech Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Hebert Kee Chan Pang | Director | — |
| Jennifer Jin | Partner | — |
| Benjamin Qiu | Partner | — |
| Jianming Yu | Founder, Managing Partner | https://shizune.co/investors/profile/jianming-yu |
| Jianming Yu | Founder, Managing Partner | https://shizune.co/investors/profile/jianming-yu-4564 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Jennifer Jin invest in?

Jennifer Jin invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Jennifer Jin?

Public channels for Jennifer Jin include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Jennifer Jin last invest?

The most recent investment recorded for Jennifer Jin closed in Jan 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co